India: Government Role In Indian Pharmaceutical Industry To Achieve Vision 2030

On June 17, 2019, a report on 'The Indian pharmaceutical industry – the way forward'1 was published by an Indian Pharmaceutical Alliance (IPA) representing research based pharmaceutical companies in collaboration with McKinsey & Co and stakeholders. The report lists the growth ambitions that Indian pharmaceutical industry ('Industry') needs to follow to achieve its targets for year 2030 (Vision 2030). The target envisages the industry to establish India as a global leader in life sciences without compromising its domestic growth including accessibility and affordability.

According to the report the industry at its current pace of 7-8% CAGR is expected to grow about USD 80 to 90 billion in annual revenue by 2030. However, with its bold aspirations of a 11-12%..... CAGR, the industry can expect to grow about USD 65 billion by 2024 and about USD 120 to 130 billion by 2030. The four bold aspirations for the industry to target Vison 2030 are:

  1. Growth in domestic market with increased accessibility and affordability.
  2. Potential innovations in next generation inventive products.
  3. Strong hold in the US market by increasing ANDA filing for upcoming off patent drugs, and potential pricing offers.
  4. Grow in unexplored/underutilized markets such as Japan and China.

To achieve this target, the Indian industry requires a huge support from the government and its regulatory bodies either in terms of regulatory policies and a supportive ecosystem or in terms of investment. The government's role is to:

  1. Accelerate universal healthcare access by strengthening the healthcare infrastructure - Improve healthcare infrastructure and increase usability of digital technologies such as telemedicine facilities, artificial intelligence, healthcare apps and, mobile clinics to accelerate the universal health coverage/access. Improved healthcare access offers a sea of opportunities for health industry including the pharma industry. In addition, the government needs to increase healthcare expenditure from its current 1.2 percent to 2.5 in next five years and then to 5 percent by 2030, in line to match the universal health access of developed economies. Moreover, the government is to empower its citizens to bear the costs of medical care either by bringing them under universal health coverage or insuring their health under 'Ayushman Bharat'.
  2. Create a stable and supportive regulatory environment for the industry - The Government can create a transparent, easy, and coherent regulatory policy which will reduce the uncertainty regarding pricing and drug approval process. Also lowering the frequency of policy revisions or setting up a periodical review framework can help resolve confusion and revive the trust of pharmaceutical companies towards the government.
  3. Create an independent Ministry for Pharmaceuticals - In order to promote the industry's interest, a dedicated Union Ministry of Pharmaceuticals can be set up by government to simplify policy making, speed-up the product approval and implementation process, and expedite investment approvals. For example, agencies like CDSCO and NPPA can be brought together under a new ministry for better coordination and quicker decision making.
  4. Primary Focus on API manufacturing to reduce the reliance on imports - The government can provide infrastructural and regulatory support to industry for manufacturing APIs by:
    1. Constructing large dedicated zones
    2. Extending pre-approval of environmental clearance
    3. Enabling existing production facilities
    4. Lowering cost of borrowing to setup API plants
  5. Promote innovation by creating a research ecosystem via -
    • Targeted tax interventions, like competitive tax breaks on R&D investments, capital gains, technology transfers, etc. For example, reducing GST on all drugs to a uniform five percent and not just limited to life saving drugs can help reduce the cost of drugs.
    • Regulatory interventions like -
      • Offering a streamlined policy for clinical trials of innovative products.
      • Offering support to health-tech start-ups and create an investor-friendly environment, with ease of doing business policies.
    • Creating anchor educational institutions for research and innovation that initiate research, provide talent to the industry and collaborate on key strategic initiatives with long-term impact.
  6. Expand and consolidate global footprint and collaborate with international regulatory bodies - The exchange of regulatory best-practices between regulatory agencies of countries will improve the market presence and also help to expedite approvals in large markets like China and Japan. The government can also work closely with the USFDA and other international regulatory bodies to communicate key issues faced by Indian pharma companies and drive the required regulatory changes.


Government support in the form of investments and regulatory interventions is integral to initiate the innovation-led growth of industry. The government has already launched some initiatives that can strengthen the industry but only to some extent; like 18.6 percent increased budgetary allocations for healthcare over five years to boost the domestic market, the launch of Ayushman Bharat Yojana to cover 50 crore beneficiaries under affordable healthcare, attracting pharma investment by intending to set up pharma parks in Andhra Pradesh, Uttar Pradesh and Haryana. Much more intent and application from the government is required for achieving vision 2030.



The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions